Skip to main content

ScienceDex / Researcher record

Jay P. McLaughlin

From the FY2025 NIH awards this investigator leads as contact PI. The department is the award's.

FY2025 NIH rank #1,374
  • R01 Holder
  • Translational
  • Top 10% Funded
  • Multi-Institutional
  • Early Career

NIH Funding · FY2025

$5.1M
Full award amounts, FY2025
5
Records listing this PI
#1,374
By linked amount among FY2025 PIs
2024
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2024$3,360,9655#2,150
2025$5,064,0915#1,374
2026$4,895,8915#2,918

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20245 records
  2. FY2025 · selected5 records
  3. FY20265 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Jay P. McLaughlin. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1894463Search this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.

FY2026 award categories

  • Anesthesiology
  • Pharmacology
  • Microbiology & Immunology

FY2025 award records by amount

NIH award records listing Jay P. McLaughlin as a PI. Multi-PI records show the full award amount for context.

  • 1UG3DA063363-01UG3Co-investigator
    Development of negative allosteric modulators at the mu opioid receptor
    $2.7M
    award amount
  • 7R01DA035714-12R01Co-investigator
    Molecular mechanisms: Dysregulation of monoamine transporters by HIV-1Tat and cocaine
    Augusta University · Pharmacology (NIH department code)
    $728.6K
    award amount
  • 5R01DA055568-03R01Contact PI
    Impacts of morphine and HIV-Tat exposures and dimethylfumarate treatment on brain BDNF and mitochondrial and behavioral dysfunction.
    University of Florida · Pharmacology (NIH department code)
    $665.6K
    award amount
  • 5R01DA057790-04R01Co-investigator
    Targeting the allosteric sodium site with novel probes for delta opioid receptor
    $656.6K
    award amount
  • 5R01DA057884-03R01Co-investigator
    Function of astrocytes autophagy in brain homeostasis and opioid-induced maladaptive behavior and addiction, in the context of HIV
    $349.3K
    award amount

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Washington University in St. Louis
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2150
  6. 2024
    Entered Top 25% Nationally
    Ranked #2150
  7. 2025
    $5M Cumulative Funding
  8. 2025
    Entered Top 10% Nationally
    Ranked #1374
  9. 2025
    Multi-Institutional Research
    Awards at 4 institutions
  10. 2025
    R01 Grant Holder
  11. 2026
    $10M Cumulative Funding